SCHEMBL6786308

SCHEMBL6786308

CC(C)c1cccc(Nc2cnn(C)c2C(=O)O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.47
BRD4 O60885 2/20 0.43
KAT2B Q92831 2/20 0.43
BRD9 Q9H8M2 2/20 0.43
BPTF Q12830 2/20 0.41
ALDH1A1 P00352 2/20 0.41
POLB P06746 1/20 0.41
FLT1 P17948 1/20 0.40
KDR P35968 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
SYK P43405 1/20 0.39
FADS1 O60427 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPK1 P28482 1/20 0.38
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
RXRG P48443 1/20 0.38
P2RX3 P56373 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6784797 0.82 PDE10A (0.56) PDE10ABRD4KAT2BBRD9BPTF
SCHEMBL6786160 0.74 BPTF (0.44) PDE10ABRD4KAT2BBRD9BPTF
SCHEMBL6789292 0.73 SMN1; SMN2 (0.48) PDE10ABRD4KAT2BBRD9BPTF
SCHEMBL6786035 0.72 FLT1 (0.56) PDE10ABRD4KAT2BBRD9BPTF
SCHEMBL6784809 0.69 CXCL8 (0.46) BRD4KAT2BBRD9BPTFPOLB
SCHEMBL16740946 0.69 KIF11 (0.54) ALDH1A1MAPTHPGDFADS1MEN1
SCHEMBL23979021 0.68 MEN1 (0.41) HPGDFADS1MEN1KMT2ARXRA
SCHEMBL30337539 0.68 MEN1 (0.41) HPGDFADS1MEN1KMT2ARXRA
SCHEMBL10094214 0.68 ALDH1A1 (0.60) ALDH1A1MAPTHPGDFADS1MEN1
SCHEMBL2096086 0.67 FADS1 (0.59) ALDH1A1HPGDFADS1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed
EP-1310498-A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PFIZER INC. (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG PDE10A 2059/4885BRD4 975/4885KAT2B 1869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.